Session Details
[3-P]Poster
Wed. Mar 18, 2026 1:00 PM - 2:00 PM JST
Wed. Mar 18, 2026 4:00 AM - 5:00 AM UTC
Wed. Mar 18, 2026 4:00 AM - 5:00 AM UTC
ポスター会場4(B105)
[3-P-061]L-Theanine may modulate neuronal excitation through the mTOR–p70S6K pathway
*Koichi Kawada1, Shinnosuke Yamaura1, Koji Komori1, Kyosuke Uno1, Yutaro Higashiura1, Kou Kawada1, Nobuyuki Kuramoto1 (1. Setsunan University, Faculty of Pharmaceutical Sciences)
[3-P-062]Curcumin Derivative J147 Attenuates ER Stress-Induced Cell Death via Suppression of CHOP Expression in HT22 Cells
*Tsugumi TANAKA1, Hiroshi Nango1, Hiroko Miyagishi1, Yasuhiro Kosuge1 (1. Lab. Pharmacol., Sch. Pharm., Nihon Univ.)
[3-P-063]Inhibitory Effects of Grape Pomace Extract (GPE) on Aβ Oligomer-Induced Neurotoxicity
*Kazuyuki Kataoka1,2,5, Mayumi Tsuji2, Mariko Haniu1,2,6, Hiroki Nagatsuka1,2,7, Tatsuya Nakanishi1,2,5, Atsushi Ishida1,2,5, Mana Tsukada3, Hiroki Shibata4, Tatsunori Oguchi1,2 (1. Department of Pharmacology, Showa Medical University Graduate School of Medicine, 2. Pharmacological Research Center, Showa Medical University, 3. Research Administration Center, Showa Medical University, 4. Hatagaoka Nature Laboratory Corporation, 5. Department of Medicine, Division of Neurology, Showa Medical University School of Medicine, 6. Department of Anesthesiology, Showa Medical University School of Medicine, 7. Department of Neurosurgery, Showa Medical University School of Medicine)
[3-P-064]Possible involvement of the thrombin-activated JNK pathway in cultured neural stem/progenitor cell proliferation
*Koki Morishige1, Nagisa Tatsuhara1, Yusuke Onaka1, Taro Yamaguchi1, Masanori Yoneyama1 (1. Laboratory of Pharmacology, Setsunan Univ.)
[3-P-065]Analysis of a novel phosphorylation mechanism of TDP-43
*Mikiro Nawa1, Masaaki Matsuoka1, Kohsuke Kanekura1 (1. Tokyo Medical University)
[3-P-066]Cigarette smoke extracts derived from heated tobacco products induced ferroptosis in the blood-brain barrier
*Shinya Dohgu1, Hisataka Aridome1, Yasuyoshi Tanaka1, Takuro Iwao1, Junichi Matsumoto1, Junko Mizoguchi1, Takahiro Horinouchi2, Fuyuko Takata1 (1. Faculty of Pharmaceutical Sciences, Fukuoka University, 2. School of Pharmacy at Narita, International University of Health and Welfare)
[3-P-067]Nanoscale organization of multiple scaffold proteins within the postsynaptic density
*Shinkuro Kobayashi1, Kenzo Hirose1 (1. Dept. Pharmacol., Grad. Sch. Med., Univ. Tokyo)
[3-P-068]Nuclear export inhibition rescues TDP-43 mislocalization and RNA splicing defects in ALS/FTD
*Kohsuke Kanekura1, Tamami Miyagi1, Mikiro Nawa1, Shinya Kusakari1, Yuka Toyama1, Hiroaki Suzuki1 (1. Tokyo Medical University)
[3-P-069]Synapse-type specific trans-synaptic nanostructures define receptor nanodomain–release site coupling
*Aiko Yokoyama1, Hirokazu Sakamoto1, Kenzo Hirose1 (1. Graduate School of Medicine, The University of Tokyo)
[3-P-070]Sialorphin potentiates effects of enkephalin without toxicity by action other than peptidase inhibition
*Takugi Kan1, Mariko Watanabe1, Masaaki Miura1, Mitsumasa Matsuda1, Kenji Ito1, Toshiyasu Suzuki1, Takeshi Suzuki1, Hiroyuki Kobayashi2, Mitsuru Kawaguchi3, Masanobu Yoshikawa2 (1. Dept. Anesthesiol. Tokai Univ. Sch. Med., 2. Dept. Clinical Pharmacol. Tokai Univ. Sch. Med., 3. Tokyo Dental Col.)
[3-P-071]Analysis of autonomic responses mediated by the central nucleus of the amygdala
*Misha Kushiro1, Nahoko Kuga1,2, Takuya Sasaki1,3 (1. Dept Pharmacol, Grad Sch Pharm, Tohoku Univ, 2. Creative Interdiscip Res Div, FRIS, Tohoku Univ, 3. Dept Neuropharmacol, Grad Sch Med, Tohoku Univ)
[3-P-072]Heart rate changes related to risk-taking behavior in a rat gambling task
*Fumiya Fukushima1, Atsushi Tamura2, Nahoko Kuga3, Takuya Sasaki1,4 (1. Tohoku University Graduate School of Pharmaceutical Sciences, 2. Osaka University Graduate School of Medicine, 3. Frontier Research Institute for Interdisciplinary Sciences, Tohoku University, 4. Tohoku University School of Medicine)
[3-P-073]NO-dependent maintenance of cerebral blood flow by the ferulic acid derivative FAD012 in a photothrombotic stroke model
*Hiroshi Sugoh1, Hirokazu Matsuzaki1, Naohiro Iwata1, Meiyan Xuan1, Jun Takayama1, Takeshi Sakamoto1, Bo Yuan1, Mari Okazaki1 (1. josai University)
[3-P-074]Effects of acute pharmacological inhibition of the prefrontal cortex or insular cortex on heart rate and blood glucose levels
*Takuma Sato1, Reina Shiratori1, Kosuke Kinoshita1, Nahoko Kuga1,2, Takuya Sasaki1,3 (1. Dept. Pharmacol., Grad. Sch. Pharm. Sci., Tohoku Univ., 2. Creative Interdiscip Res Div, FRIS, Tohoku Univ., 3. Dept. Neuropharmacol., Grad. Sch. Med., Tohoku Univ.)
[3-P-075]Role of Thyroid Hormone Receptor α in Chemical-Induced Developmental Neurotoxicity
*Shigeru Yamada1, Yasunari Kanda1 (1. National institute of health science)
[3-P-076]Finely Patterned Photostimulation for In Vivo Manipulation of Neural Activity
*Yamato Ishii1, Ryosuke Yoshida1, Kotaro Yamashiro1, Kei Furuya2, Tianben Ding2, Keisuke Goda2,3,4, Nobuyoshi Matsumoto1,5, Yuji Ikegaya1,5 (1. Graduate School of Pharmaceutical Sciences, The University of Tokyo, 2. Department of Chemistry, The University of Tokyo, 3. Institute of Technological Sciences, Wuhan University, 4. Department of Bioengineering, University of California, 5. Institute for AI and Beyond, The University of Tokyo)
[3-P-077]Sex differences in neurons of the nucleus of the solitary tract innervated by the vagus nerve
*Miiro Goto1, Musashi Yamakawa1, Kento Ohbayashi3, Yusaku Iwasaki3, Sasaki Takuya1,2, Hiroyuki Igarashi1 (1. Grad. Sch. Pharm. Sci., Tohoku Univ., 2. Grad. Sch. Med., Tohoku Univ., 3. Grad. Sch. Life and Environmental Sci., Kyoto Prefectural Univ.)
[3-P-078]Therapeutic Effects of Molecular Hydrogen on Acetaminophen-Induced Liver Injury in Diabetic Mice
*Naomi Kamimura1, Katsuya Iuchi2, Tsutomu Igarashi3, Ikuroh Ohsawa4, Chikako Nito1, Jitsuo Usuda1, Shigeo Ohta5 (1. Lab. Clin. Res., Collab. Res. Ctr., Nippon Med. Sch., 2. FRIS, Tohoku Univ., 3. Dept. Ophthalmology, NMS Hokusoh Hosp., 4. Mol. Hydrogen Med., TMIG, 5. Dept. Neurol. Med., Grad. Med. Sch., Juntendo Univ.)
[3-P-079]Therapeutic Efficacy of Resmetirom and Semaglutide in the STAM Mouse Model From Surrogate Endpoints toward Clinical Outcome Evaluation
*Taishi Hashiguchi1 (1. SMC Laboratories)
[3-P-080]Inhibitory effect of RAMP1 signaling on MASLD progression
*Kanako Hosono1,2, Mina Tanabe1, Tomohiro Betto3, Atsushi Yamashita4, Mariko Kamata1,2, Yoshiya Ito1,2, Kazutake Tsujikawa5, Hideki Amano1,2 (1. Dept. Pharm., Sch. Med., Kitasato Univ., 2. Dept. Mol. Pharm., Grad. Sch. Med., Kitasato Univ., 3. Dept.Gastroenterol, Sch. Med., Kitasato Univ., 4. Dept. Anesth., Sch. Med., Kitasato Univ., 5. Grad. Sch. Pharm. Sci., Osaka Univ.)
[3-P-081]Purinergic signaling regulation of mucus secretion from the murine colonic epithelium
*Kazuki Yoshida1, Nozomi Suto1, Musashi Hagiwara1, Masa-aki Ito1, Isao Matsuoka1 (1. Takasaki university of health and welfare)
[3-P-082]Evaluation of drug-induced liver injury utilizing hepatocyte spheroids derived from humanized mouse liver
*Xingming Liu1, Yuichiro Higuchi2, Yuta Sakamoto1, Shota Yanagida1, Shotaro Uehara2, Hiroshi Suemizu2, Yasunari Kanda1, Hiroyuki Kawagishi1 (1. Division of Pharmacology, National Institute of Health Sciences, 2. Central Institute for Experimental Medicine and Life Science)
[3-P-083]Evaluation of lipid-lowering drugs using a 3D in vitro MASH model
*Yuya Asano1, Ayu Inoue2, Hiroyuki Kobayashi1, Saeko Hamanaka1, Takahito Imaizimi1, Tadashi Ito1, Natsuko Yoshida1, Yukiko Kawasaki1, Toshihiko Maekawa2, Aya Sugai2, Yasushi Hirasawa1 (1. Nihon Bioresearch Inc., 2. Cyfuse Biomedical K.K.)
[3-P-084]Involvement of Group I Metabotropic Glutamate Receptors in L-Glutamate–Induced Hepatocyte Proliferation.
*Hajime Moteki1, Nozomi Takeuchi1, Masahiko Ogihara1, Mitsutoshi Kimura1 (1. Josai University)